“Tildrakizumab Efficacy by Metabolic Syndrome Status in Psoriasis: Post Hoc Analysis of 3-Year Data from the Phase 3 Resurface 1 And Resurface 2 Studies”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s42. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/991.